Turmeric (Curcuma longa), a rhizomatous herbaceous perennial plant of the ginger family,
has been used for the treatment of diabetes in Ayurvedic and traditional Chinese medicine …

Background Tumor necrosis factor-α (TNF-α) is a key inflammatory mediator and its
reduction is a therapeutic target in several inflammatory diseases. Curcumin, a bioactive …

Despite significant advances in treatment modalities over the last decade, neither the
incidence of the disease nor the mortality due to cancer has altered in the last thirty years …

The development of oral dosage forms that allows absorption of therapeutic peptides to the
systemic circulation is one of the greatest challenges for the pharmaceutical industry …

Epithelial-to-mesenchymal transition (EMT) is a self-regulated physiological process
required for tissue repair that, in non-controled conditions may lead to fibrosis …

Curcumin, an active polyphenol of the golden spice turmeric, is a highly pleiotropic molecule
with the potential to modulate the biological activity of a number of signaling molecules …

Progressive accumulation of misfolded amyloid proteins in intracellular and extracellular
spaces is one of the principal reasons for synaptic damage and impairment of neuronal …

Curcumin, a plant-derived polyphenolic compound, naturally present in turmeric (Curcuma
longa), has been the subject of intensive investigations on account of its various activities …

Curcumin is a polyphenol natural product isolated from turmeric, interacting with different
cellular and molecular targets and, consequently, showing a wide range of pharmacological …

TNFs are major mediators of inflammation and inflammation‐related diseases, hence, the U
nited S tates F ood and D rug A dministration (FDA) has approved the use of blockers of the …